Search Within

Jaap Jan Boelens

  1. "Kevin Curran"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (16)
  3. Research Letter (2)
Groups
  1. Pediatrics, Department of (45)
  2. Stem Cell Transplantation and Cellular Therapy Service (45)
  3. Tow Center for Developmental Oncology (TCDO) (45)
  4. Department of Medicine (35)
  5. GSK Faculty (30)
  6. Sloan Kettering Institute Faculty (30)

More Groups

People
  1. Kevin Curran (45)
  2. Andromachi Scaradavou (33)
  3. Maria Cancio (31)
  4. Nancy Kernan (28)
  5. Richard O'Reilly (27)
  6. Barbara Spitzer (24)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (5)
  6. 2020 (8)

More Years

Publications
  1. Bone Marrow Transplantation (12)
  2. Cytotherapy (9)
  3. Biology of Blood and Marrow Transplantation (5)
  4. Blood (5)
  5. Blood Advances (5)
  6. Transplantation and Cellular Therapy (4)

More Publications

Publishers
  1. Nature Publishing Group (12)
  2. American Society of Hematology (10)
  3. Elsevier Inc. (9)
  4. Elsevier Science Ltd. (9)
  5. Wiley Periodicals, Inc (2)
  6. Frontiers Media S.A. (1)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Identification of infants with non-SCID immune deficiency by newborn screening for SCID - The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Prockop, S.; Spitzer, B.; Walsh, M.; Ruggiero, J.; Kennedy, J.; Boulad, F.; Cancio, M.; Curran, K.; Kernan, N.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save